Small interfering ribonucleic acid (rna) market to reach $47.07 billion by 2030 at 20.0% CAGR, driven by rising demand for personalized medicine and targeted gene silencing therapies.
Read More
Small cell lung cancer therapeutics market to reach $13.95 billion by 2030 at 13.4% CAGR, driven by increasing prevalence of lung cancer and advancements in targeted therapies.
Read More
Sleeping pills market to reach $126.55 billion by 2030 at 8.0% CAGR, driven by increasing prevalence of mental illness and rising demand for effective insomnia treatments.
Read More
Sleep supplements market to reach $10.07 billion by 2030 at 6.1% CAGR, driven by increasing work-related stress levels and growing preference for natural sleep solutions.
Read More
Sleep patches market to reach $184.43 billion by 2030 at 19.2% CAGR, driven by increasing prevalence of sleeping disorders and rising healthcare spending globally.
Read More
Sleep medication market to reach $38.05 billion by 2030 at 7.9% CAGR, driven by increasing prevalence of mental illness and growing awareness of sleep health.
Read More
Skin health supplements and treatment market to reach $9.44 billion by 2030 at 8.2% CAGR, driven by increasing prevalence of skin disorders caused by pollution and environmental factors.
Read More
Skin care supplements market to reach $4.24 billion by 2030 at 6.5% CAGR, driven by growth of e-commerce platforms and increasing consumer focus on preventive skincare.
Read More
Skin cancer drugs market to reach $9.12 billion by 2030 at 11.7% CAGR, driven by increased sun exposure, tanning habits, and rising awareness of advanced skin cancer treatments.
Read More
Skin Booster Industry Poised for Rapid Growth, Forecast to Touch $2.09 Billion by 2030 at 10.7% CAGR
Skin booster market to reach $2.09 billion by 2030 at 10.7% CAGR, driven by growing demand for wrinkle treatment and rising adoption of minimally invasive aesthetic procedures.
Read More